Adage Capital Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114M | Buy |
|
|||||
|
2025
Q1 | $63.5M | Buy |
|
|||||
|
2024
Q4 | $6.16M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.67M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.6M | Sell |
|
|||||
|
2023
Q1 | $25.7M | Sell |
|
|||||
|
2022
Q4 | $36.1M | Buy |
|
|||||
|
2022
Q3 | $591K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $7.59M | Sell |
|
|||||
|
2021
Q4 | $8.47M | Hold |
|
|||||
|
2021
Q3 | $7.98M | Hold |
|
|||||
|
2021
Q2 | $9.74M | Buy |
|
|||||
|
2021
Q1 | $7.29M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.64M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $4.01M | Sell |
|
|||||
|
2018
Q4 | $4.18M | Buy |
|
|||||
|
2018
Q3 | $6.86M | Sell |
|
|||||
|
2018
Q2 | $14M | Sell |
|
|||||
|
2018
Q1 | $29.2M | Sell |
|
|||||
|
2017
Q4 | $41.4M | Sell |
|
|||||
|
2017
Q3 | $22.5M | Sell |
|
|||||
|
2017
Q2 | $9.76M | Buy |
|
|||||
|
2017
Q1 | $6.16M | Buy |
|
|||||
|
2016
Q4 | $5.21M | Buy |
|